Found: 26
Select item for more details and to access through your institution.
Concomitant JAK2 mutated myeloproliferative neoplasms and hereditary hemochromatosis.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Chronic Myelomonocytic Leukemia: Insights into Biology, Prognostic Factors, and Treatment.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 11, p. 1, doi. 10.1007/s11912-019-0855-6
- By:
- Publication type:
- Article
Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature.
- Published in:
- Clinical & Experimental Medicine, 2020, v. 20, n. 2, p. 313, doi. 10.1007/s10238-020-00616-5
- By:
- Publication type:
- Article
RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23186-w
- By:
- Publication type:
- Article
Response to erythropoiesis‐stimulating agents in patients with WHO‐defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN‐RS‐T).
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 3, p. e104, doi. 10.1111/bjh.16515
- By:
- Publication type:
- Article
Mutation‐enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 2, p. 291, doi. 10.1111/bjh.16380
- By:
- Publication type:
- Article
The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation‐enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosis.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 1, p. 68, doi. 10.1002/ajh.27136
- By:
- Publication type:
- Article
SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlates.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 9, p. E347, doi. 10.1002/ajh.26648
- By:
- Publication type:
- Article
Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 846, doi. 10.1002/ajh.26548
- By:
- Publication type:
- Article
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real‐life setting: An Italian MYNERVA Project.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 7, p. 8166, doi. 10.1002/cam4.5618
- By:
- Publication type:
- Article
The Role of Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Past, Present, and Future Directions.
- Published in:
- Bioengineering (Basel), 2023, v. 10, n. 5, p. 591, doi. 10.3390/bioengineering10050591
- By:
- Publication type:
- Article
Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00786-x
- By:
- Publication type:
- Article
Differential prognostic impact of cytopenic phenotype in prefibrotic vs overt primary myelofibrosis.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 8, p. 1, doi. 10.1038/s41408-022-00713-6
- By:
- Publication type:
- Article
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00581-6
- By:
- Publication type:
- Article
Mutations and thrombosis in essential thrombocythemia.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 2, p. 1, doi. 10.1038/s41408-020-0289-2
- By:
- Publication type:
- Article
Thrombotic risk correlates with mutational status in true essential thrombocythemia.
- Published in:
- European Journal of Clinical Investigation, 2016, v. 46, n. 8, p. 683, doi. 10.1111/eci.12647
- By:
- Publication type:
- Article
Phenotypic correlates and prognostic outcomes of TET2 mutations in myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: A comprehensive study of 504 adult patients.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 4, p. E86, doi. 10.1002/ajh.25721
- By:
- Publication type:
- Article
Cutaneous blastic plasmacytoid dendritic cell neoplasm arising in the context of TET2 and ZRSR2 mutated clonal cytopenias of unknown significance, secondary to somatic copy number losses involving CDK2NA/2NB and MTAP.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 2, p. E31, doi. 10.1002/ajh.25675
- By:
- Publication type:
- Article
Characteristics and clinical correlates of NFE2 mutations in chronic Myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. E23, doi. 10.1002/ajh.25668
- By:
- Publication type:
- Article
Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 9, p. E239, doi. 10.1002/ajh.25555
- By:
- Publication type:
- Article
Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 9, p. E231, doi. 10.1002/ajh.25552
- By:
- Publication type:
- Article
Gender and survival in essential thrombocythemia: A two-center study of 1,494 patients.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 11, p. 1193, doi. 10.1002/ajh.24882
- By:
- Publication type:
- Article
A life-threatening ruxolitinib discontinuation syndrome.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 8, p. 833, doi. 10.1002/ajh.24775
- By:
- Publication type:
- Article
Integration of Molecular Information in Risk Assessment of Patients with Myeloproliferative Neoplasms.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 8, p. 1962, doi. 10.3390/cells10081962
- By:
- Publication type:
- Article
Hematologic Neoplasms Associated with Down Syndrome: Cellular and Molecular Heterogeneity of the Diseases.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 20, p. 15325, doi. 10.3390/ijms242015325
- By:
- Publication type:
- Article